BRCA2 and neoplasm: Our results reveal that reducing AURKB levels is the key to reversing the growth inhibition caused by BRCA2 deficiency–induced K-fiber instability and SAC activation, so how to reactivate the recognition of deficient K-fibers and ultimately kill BRCA2-deficient tumor cells is a very important issue.